المؤلفون: Park, John, Rugo, HS, Jo, A, Franco, SX, Stopeck, AT, Glencer, A, Lahiri, S, Arbushites, MC, Scott, J, Park, JW, Hudis, C

URL الوصول: https://escholarship.org/uc/item/2z30g6mg

المؤلفون: Di Leo A, Gomez HL, Aziz Z, Zvirbule Z, Bines J, Arbushites MC, Guerrera SF, Koehler M, Oliva C, Stein SH, Williams LS, Dering J, Finn RS, Press MF, Di Leo, Angelo, Gomez, Henry L, Aziz, Zeba, Zvirbule, Zanete, Bines, Jose, Arbushites, Michael C

المصدر: Journal of Clinical Oncology; 12/1/2008, Vol. 26 Issue 34, p5544-5552, 9p

المؤلفون: Gomez HL, Doval DC, Chavez MA, Ang PC, Aziz Z, Nag S, Ng C, Franco SX, Chow LW, Arbushites MC, Casey MA, Berger MS, Stein SH, Sledge GW

المصدر: Journal of Clinical Oncology; 6/20/2008, Vol. 26 Issue 18, p2999-3005, 7p

المؤلفون: Pratta M; Incyte Research Institute, Wilmington, Delaware, USA., Paczesny S; Hollings Cancer Center, Charleston, South Carolina, USA., Socie G; Hematology-Transplantation AP-HP Hospital Saint Louis, INSERM UMR 976, University of Paris, Paris, France., Barkey N; Incyte Research Institute, Wilmington, Delaware, USA., Liu H; Incyte Research Institute, Wilmington, Delaware, USA., Owens S; Incyte Research Institute, Wilmington, Delaware, USA., Arbushites MC; Incyte Research Institute, Wilmington, Delaware, USA., Schroeder MA; Washington University School of Medicine, St. Louis, Missouri, USA., Howell MD; Incyte Research Institute, Wilmington, Delaware, USA.

المصدر: British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (4), pp. 729-739. Date of Electronic Publication: 2022 Jun 11.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/drug therapy , Graft vs Host Disease*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects, Acetonitriles ; Acute Disease ; Adrenal Cortex Hormones/therapeutic use ; Biomarkers ; Humans ; Proteomics ; Pyrazoles ; Pyrimidines ; Pyrroles

المؤلفون: Jagasia M; Vanderbilt University Medical Center, Nashville, TN., Perales MA; Memorial Sloan-Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Schroeder MA; Section of Blood and Marrow Transplant, Division of Oncology, Department of Medicine, Washington University, St. Louis, MO., Ali H; City of Hope, Duarte, CA., Shah NN; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Chen YB; Massachusetts General Hospital, Boston, MA., Fazal S; Allegheny Health Network, Pittsburgh, PA., Dawkins FW; Incyte Corporation, Wilmington, DE., Arbushites MC; Incyte Corporation, Wilmington, DE., Tian C; Incyte Corporation, Wilmington, DE., Connelly-Smith L; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA.; Fred Hutchinson Cancer Research Center, Seattle, WA; and., Howell MD; Incyte Corporation, Wilmington, DE., Khoury HJ; Winship Cancer Institute of Emory School of Medicine, Atlanta, GA.

المصدر: Blood [Blood] 2020 May 14; Vol. 135 (20), pp. 1739-1749.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease/*drug therapy , Hematologic Neoplasms/*therapy , Hematopoietic Stem Cell Transplantation/*adverse effects , Pyrazoles/*therapeutic use, Adolescent ; Adrenal Cortex Hormones/therapeutic use ; Adult ; Aged ; Drug Resistance/drug effects ; Female ; Graft vs Host Disease/etiology ; Humans ; Male ; Middle Aged ; Nitriles ; Pyrimidines ; Remission Induction ; Treatment Outcome ; Young Adult

المؤلفون: Schroeder MA; Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine in St. Louis, St. Louis, MO., Khoury HJ; Division of Hematology, Winship Cancer Institute of Emory School of Medicine, Atlanta, GA., Jagasia M; Vanderbilt-Ingram Cancer Center, Nashville, TN., Ali H; City of Hope National Medical Center, Duarte, CA., Schiller GJ; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA., Staser K; Department of Dermatology, Washington University School of Medicine in St Louis, St Louis, MO., Choi J; Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine in St. Louis, St. Louis, MO., Gehrs L; Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine in St. Louis, St. Louis, MO., Arbushites MC; Incyte Corporation, Wilmington, DE., Yan Y; Incyte Corporation, Wilmington, DE., Langmuir P; Incyte Corporation, Wilmington, DE., Srinivas N; Incyte Corporation, Wilmington, DE., Pratta M; Incyte Corporation, Wilmington, DE., Perales MA; Memorial Sloan Kettering Cancer Center, New York, NY., Chen YB; Massachusetts General Hospital, Boston, MA; and., Meyers G; Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., DiPersio JF; Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine in St. Louis, St. Louis, MO.

المصدر: Blood advances [Blood Adv] 2020 Apr 28; Vol. 4 (8), pp. 1656-1669.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/drug therapy , Hematopoietic Stem Cell Transplantation*/adverse effects, Adolescent ; Adrenal Cortex Hormones ; Adult ; Humans ; Janus Kinase 1 ; Protein Kinase Inhibitors/adverse effects ; Steroids

المؤلفون: Tenori L; Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy., Oakman C, Claudino WM, Bernini P, Cappadona S, Nepi S, Biganzoli L, Arbushites MC, Luchinat C, Bertini I, Di Leo A

المصدر: Molecular oncology [Mol Oncol] 2012 Aug; Vol. 6 (4), pp. 437-44. Date of Electronic Publication: 2012 Jun 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Metabolome* , Metabolomics*, Breast Neoplasms/*blood , Breast Neoplasms/*metabolism, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/drug therapy ; Clinical Trials, Phase III as Topic ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Lapatinib ; Neoplasm Metastasis ; Paclitaxel/therapeutic use ; Pilot Projects ; Quinazolines/therapeutic use ; Randomized Controlled Trials as Topic ; Receptor, ErbB-2/metabolism ; Survival Analysis ; Time Factors ; Treatment Outcome

المؤلفون: Rugo HS; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., 2nd Floor, Box 1710, B-608, San Francisco, CA 94143, USA. hrugo@medicine.ucsf.edu, Chien AJ, Franco SX, Stopeck AT, Glencer A, Lahiri S, Arbushites MC, Scott J, Park JW, Hudis C, Nulsen B, Dickler MN

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Jul; Vol. 134 (1), pp. 13-20. Date of Electronic Publication: 2011 Dec 24.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*drug therapy , Receptor, ErbB-2/*metabolism, Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Disease-Free Survival ; Female ; Humans ; Lapatinib ; Middle Aged ; Neoplasm Metastasis ; Proportional Hazards Models ; Quinazolines/administration & dosage ; Receptor, ErbB-2/genetics ; Treatment Outcome

المؤلفون: Blackwell KL; Department of Medicine/Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA. black034@mc.duke.edu, Pegram MD, Tan-Chiu E, Schwartzberg LS, Arbushites MC, Maltzman JD, Forster JK, Rubin SD, Stein SH, Burstein HJ

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2009 Jun; Vol. 20 (6), pp. 1026-31. Date of Electronic Publication: 2009 Jan 29.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Breast Neoplasms/*drug therapy , Breast Neoplasms/*metabolism , Quinazolines/*therapeutic use, Adult ; Aged ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Breast Neoplasms/pathology ; Breast Neoplasms/secondary ; Disease Progression ; Female ; Humans ; Lapatinib ; Middle Aged ; Receptor, ErbB-2/biosynthesis ; Trastuzumab ; Treatment Failure ; Treatment Outcome